Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

148 evidence items · page 5 / 6

65.8 %More than half (65.8%) of the respondents were willing to vaccinate their adolescents against HPV.

Nigeriainfection à HPVpublished 2023West African journal of medicinePubMeddocument of 3 observations

6.8 aORAmong participants in the TRUST/RV368 cohort, 12 years or longer since anal coital debut was associated with highly similar anal HPV genotypes at 12 months (adjusted odds ratio 6.8, 95% CI 3.1–5.2).

Nigeriainfection à HPVpublished 2022Sexually transmitted diseasesPubMeddocument of 13 observations

92 %Among 342 men who have sex with men (MSM) in Nigeria, the prevalence of any HPV was 92%.

Nigeriainfection à HPVpublished 2020Papillomavirus research (Amsterdam, Netherlands)PubMeddocument of 19 observations

Mean HPV knowledge scores increased from 5.36 ± 6.26 to 23.41 ± 2.51 after the intervention.

Nigeriainfection à HPVPubMeddocument of 7 observations

19 %Among 213 women aged 16 to 63 years recruited in Lagos, Nigeria, 35 out of 187 concordant results were HPV positive, representing 19% of concordant cases.

Nigeriainfection à HPVobserved 2020published 2022BMC public healthPubMeddocument of 5 observations

66.05 %Knowledge of HPV and cervical cancer among junior secondary school aged girls had a mean score of 66.05%.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2022BMC public healthPubMeddocument of 6 observations

96.8 %Almost all of the parents (96.8%) had the intention to vaccinate their adolescents with HPV vaccine.

Nigeriainfection à HPVpublished 2022Human vaccines & immunotherapeuticsPubMeddocument of 3 observations

16.3 %In the study, 48 out of 295 individuals (16.3%) were successfully genotyped for HPV.

Nigeriainfection à HPVpublished 2019PloS onePubMeddocument of 7 observations

20 %Twenty percent of participants in the TRUST/RV368 cohort had highly similar anal HPV genotypes at 12 months.

Nigeriainfection à HPVpublished 2022Sexually transmitted diseasesPubMeddocument of 13 observations

42.4 %42.4% of the respondents have heard of HPV infection.

Nigeriainfection à HPVpublished 2023African journal of reproductive healthPubMeddocument of 5 observations

96.4 %Nearly all participants with oral HPV and EBV co-infection were females (96.4%).

Nigeriainfection à HPV · virus Epstein-Barrpublished 2025BMC oral healthPubMeddocument of 4 observations

53 %Fifty-three percent of participants in the TRUST/RV368 cohort had highly similar anal HPV genotypes at 3 months.

Nigeriainfection à HPVpublished 2022Sexually transmitted diseasesPubMeddocument of 13 observations

96 %Following the intervention, 96% of female secondary school students achieved high HPV knowledge.

Nigeriainfection à HPVPubMeddocument of 7 observations

13.2 %HPV was found in 13.2% of vaginal swabs among girls aged 9–20 years in central Nigeria.

Nigeriainfection à HPVpublished 2022BMC infectious diseasesPubMeddocument of 8 observations

63 %The prevalence of parental HPV vaccine acceptance was 63.0% among respondents in Abia State, Nigeria.

Nigeriainfection à HPVobserved 2023published 2025The Pan African medical journalPubMeddocument of 10 observations

96.25 %Knowledge of HPV and cervical cancer among senior secondary school aged girls had a mean score of 96.25%.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2022BMC public healthPubMeddocument of 6 observations

75 %The prevalence of any HPV infection was 75% in the anus among female sex workers in Ibadan, Nigeria.

Nigeriainfection à HPVpublished 2022PloS oneeurope_pmcdocument of 4 observations

50 %HPV-16 seroprevalence among women aged 15–19 years in Central Nigeria was 50.0%.

Nigeriainfection à HPVobserved August 2016 to January 2018published 2021The Pan African medical journalPubMeddocument of 17 observations

3 %Awareness of HPV-associated oropharyngeal and female HPV-associated cancers ranged from 3% to 7% among the participants.

Nigeriafemale HPV-associated cancers · infection à HPV · oropharyngeal cancerpublished 2025Sexual healthPubMeddocument of 9 observations

42 %The overall pooled prevalence of cervical papillomavirus infection was 42% in the general population in Nigeria.

Nigeriainfection à HPVpublished 2020Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 2 observations

89.8 %Compared to the medic-collected sample, the self-collected sample was 89.80% sensitive and 98.21% specific, with an accuracy of 96.31%, as determined using real-time PCR assay for HPV detection.

Nigeriainfection à HPVobserved 2020published 2022BMC public healthPubMeddocument of 5 observations

40.98 %Among the PCR-confirmed HPV types, 40.98% were high-risk HPV types.

Nigeriainfection à HPVpublished 2023Virology journalPubMeddocument of 8 observations

1.3 %One point three percent of women had unresolved HPV infections.

Nigeriainfection à HPVpublished 2026Diagnostic microbiology and infectious diseasePubMeddocument of 21 observations

53.3 %About 53.3% of female undergraduates in a university in Ekiti State, southwest Nigeria, had fair knowledge of HPV.

Nigeriainfection à HPVpublished 2023African journal of reproductive healthPubMeddocument of 5 observations

18.2 %In the study, 18.2% of refusals for the HPV vaccine were due to fear of needles among students in four secondary schools in Benin City, Nigeria.

Nigeriainfection à HPVpublished 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 10 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.